Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merit Medical

84.52
+0.37000.44%
Volume:398.48K
Turnover:33.72M
Market Cap:5.01B
PE:42.85
High:85.41
Open:84.65
Low:84.09
Close:84.15
52wk High:111.45
52wk Low:78.12
Shares:59.22M
Float Shares:57.83M
Volume Ratio:0.96
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.97
EPS(LYR):2.07
ROE:8.60%
ROA:4.19%
PB:3.36
PE(LYR):40.88

Loading ...

Oct 17, 2025

Major Issues Report

Form 8-K - Current report
Oct 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jul 11, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Major Issues Report

Form 8-K - Current report
May 19, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 24, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]